期刊文献+

去势Beagle犬前列腺增生模型的建立 被引量:11

Establishment of Prostatic Hyperplasia Model with Castration Beagle Canines
下载PDF
导出
摘要 目的 :利用Beagle犬建立前列腺增生模型。 方法 :2年龄雄性Beagle犬 2 4只 ,随机分成对照组和 3个剂量的实验组共 4组 ,每组 6只 ,去势 2个月后 ,肌注给药。实验组分别给予丙酸睾酮 (TP) 0 .8、2 .5、7.5mg/kg ,对照组给予等体积溶剂。 2个月后 ,处死 12只动物 ,取前列腺组织 ,称重测量体积 ,放免法测定血清及前列腺组织中双氢睾酮 (DHT)水平 ,组织切片观察前列腺腺腔面积及腺上皮细胞高度。B超测量去势前、后 2个月及给予TP 2个月时犬前列腺体积。 结果 :B超结果显示 ,去势 2个月后 ,各组犬前列腺体积较去势前均明显缩小 (P均 <0 .0 1) ;给予TP 2个月后 ,各实验组犬前列腺体积明显大于对照组 (P均 <0 .0 1)。各实验组犬前列腺湿重及实际体积与对照组相比 ,均明显增重增大 (P均 <0 .0 5 ) ,并存在剂量依赖关系。犬血清及前列腺中DHT含量随TP剂量的增大而增加。显微图像分析结果显示 ,犬前列腺腺腔面积随TP剂量增大而增加 ,腺上皮细胞高度也随TP剂量增大而增高。 结论 :给予去势Beagle犬TP 2个月后 ,可成功建立前列腺增生模型。 Objective: To establish a prostatic hyperplasia model with Beagle canines. Methods: Twenty-four two-year-old male Beagle canines were divided into treatment and control groups at random and were administrated testosterone propionate (TP) through intramuscular injection two months after castration. Three treatment groups were given 0.8, 2.5 and 7.5 mg/kg TP respectively, and the control was given the same volume of vehicle. Two months later, half of the animals were killed and the serum and prostate were prepared. After the wet weight and volume of prostate were measured, the dihydrotestosterone (DHT) level of serum and prostate were detected with DHT radioimmunoassay (RIA) kit, and paraffine section from canine prostate was stained by the HE methods. Pictures were taken by digital camera under microscope, and all the pictures were analyzed by computer for epithelial cell height and acinar luminal area of prostate with micro image analysis software. The canine prostate volume was measured with ultrasonic diagnosis instrument before castration, at two months after castration and at two months after being given TP. Results: The ultrasonic results showed that the prostate volumes of all the canines were smaller at two months after castration than before castration (P< 0.05), and after having been administrated TP for two months, and the prostate volumes of all treatment groups were larger than those of the control group (P< 0.01). The wet weight of the prostate of the treatment group was higher than that of the control group (P< 0.05), and both had dose-dependent relationship. The DHT level of serum and prostate of the canines became higher with the increase of TP dose. The results of micro image analysis showed that the acinar luminal area of prostate was enlarged, and the epithelial cell height increased with larger dose of TP. Conclusions: It is practicable to establish prostatic hyperplasia model in Beagle canines after two months of TP administration.
出处 《中华男科学杂志》 CAS CSCD 2003年第6期425-428,共4页 National Journal of Andrology
基金 上海市科技发展基金 (科技攻关 )项目 (0 0 49190 73)
关键词 丙酸睾酮 前列腺增生 动物模型 去势 BEAGLE犬 Testosterone propionate Prostatic hyperplasia Animal model Castration Beagle canine
  • 相关文献

参考文献8

二级参考文献20

  • 1王晓东,贾悦,崔毓桂,狄福松,王兴海,童建孙,马鼎志,蔡瑞芬.爱普列特对雄性大鼠生精功能的影响[J].药学进展,2002,26(1):58-60. 被引量:3
  • 2Audet P R , Baine N H, Benincosa L J, et al. Epristeride steroid 5α-reductase inhibitor treatment for benign prostatic hyperplasia[J]. Drugs Fut, 1994, 19(7): 646-50.
  • 3Metcalf B W, Holt D A, Levy M A,et al. Communication:potent inhibition of human steroid 5α-reductase (Ec 1.3. 1.30) by 3-androstene-3-carboxylic acids[J]. Bioorg Chem,1989,17: 372-376.
  • 4George F W, Johnson L, Wilson J D. The effect of a 5(-reductase inhibitor on androgen physiology in the immature male rat[J]. Endocrinology, 1989, 125: 2434-2438.
  • 5Holt D A, Levy M A, Ladd D L, et al. Steroidal a ring aryl carboxyiic acid: a new class steroid 5a-reductase inhibitors[J]. J Med Chem, 1990,33:937-942.
  • 6Baine N H, Owings F F, Kline D N, et al. Improved syntheses of epristeride, a potent human 5a-reductase inhibitor[J]. J Org Chem, 1994,59:5987-5989.
  • 7刘照旭,范医东,方笑雷.前列腺疾病的诊断与治疗(第1版)[M].山东:山东科学技术出版社,1998.
  • 8Geller J, Sionit L. Basic studies and clinical experience with finasteride[J]. J Endocrinol Invest, 1994, 17 (suppl 1-3):15.
  • 9Lanb J C, Levy M A, Johnson R K, et al. Response of rat and human prostatic cancers to the novel 5A-reductase inhibitor, SK&F 105657[J]. The Prostate, 1992, 21: 15-34.
  • 10Levy M A, Brandt M, Sheedy K M, et al. Interaction between rat prostatic steroid 5a-reductase and 3-carboxy- 17β-substituted steroids: novel mechanism of enzyme inhibition[J]. J Steroid Biochem, 1989, 34(1-6): 571-575.

共引文献50

同被引文献128

引证文献11

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部